Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Non-Current Debt (2021 - 2023)

Historic Non-Current Debt for Pulse Biosciences (PLSE) over the last 3 years, with Q1 2023 value amounting to $65.0 million.

  • Pulse Biosciences' Non-Current Debt changed N/A to $65.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was $65.0 million, marking a year-over-year change of. This contributed to the annual value of $65.0 million for FY2022, which is N/A changed from last year.
  • Pulse Biosciences' Non-Current Debt amounted to $65.0 million in Q1 2023.
  • Pulse Biosciences' Non-Current Debt's 5-year high stood at $65.0 million during Q3 2022, with a 5-year trough of $41.0 million in Q1 2021.
  • Over the past 3 years, Pulse Biosciences' median Non-Current Debt value was $65.0 million (recorded in 2022), while the average stood at $59.0 million.